최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0768221 (2001-01-22) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 756 인용 특허 : 24 |
An implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with an external device via telemetry. Each proce
An implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with an external device via telemetry. Each processor controls a different part of the drug infusion mechanism such that both processors must agree on the appropriateness of drug delivery for infusion to occur. Delivery accumulators are incremented and decremented with delivery requests and with deliveries made. When accumulated amounts reach or exceed, quantized deliverable amounts, infusion is made to occur. The accumulators are capable of being incremented by two or more independent types of delivery requests. Operational modes of the infusion device are changed automatically in view of various system errors that are trapped, various system alarm conditions that are detected, and when excess periods of time lapse between pump and external device interactions.
An implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with an external device via telemetry. Each proce
An implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with an external device via telemetry. Each processor controls a different part of the drug infusion mechanism such that both processors must agree on the appropriateness of drug delivery for infusion to occur. Delivery accumulators are incremented and decremented with delivery requests and with deliveries made. When accumulated amounts reach or exceed, quantized deliverable amounts, infusion is made to occur. The accumulators are capable of being incremented by two or more independent types of delivery requests. Operational modes of the infusion device are changed automatically in view of various system errors that are trapped, various system alarm conditions that are detected, and when excess periods of time lapse between pump and external device interactions. et al., 128/419.PG; US-4949719, 19900800, Pless et al., 128/419.D; US-4953551, 19900900, Mehra et al., 128/419.D; US-5099838, 19920300, Bardy, 128/419.D; US-5117824, 19920600, Keimel et al., 128/419.D; US-5127404, 19920700, Wyborny et al., 128/419.P; US-5131388, 19920700, Pless et al., 128/419.D; US-5144949, 19920900, Olson, 128/419.PG; US-5158078, 19921000, Bennett et al., 128/419.PG; US-5163427, 19921100, Keimel, 128/419.D; US-5188105, 19930200, Keimel, 128/419.D; US-5199428, 19930400, Obel et al., 128/419.C; US-5207218, 19930500, Carpentier et al., 128/419.PG; US-5269298, 19931200, Adams et al., 128/419.D; US-5292343, 19940300, Blanchette et al., 607/032; US-5312453, 19940500, Shelton et al., 607/019; US-5314430, 19940500, Bardy, 607/005; US-5330507, 19940700, Schwartz, 607/014; US-5331966, 19940700, Bennett et al., 128/696; US-5344431, 19940900, Merritt et al., 607/029; US-5345362, 19940900, Winkler, 361/681; US-5354316, 19941000, Keimel, 607/015; US-5354319, 19941000, Wyborny et al., 607/032; US-5374282, 19941200, Nichols et al., 607/018; US-5402794, 19950400, Wahlstrand et al., 128/696; US-D358583, 19950500, Winkler, D14/106; US-5545186, 19960800, Olson et al., 607/014; US-5620473, 19970400, Poore, 607/027; US-5690686, 19971100, Min et al., 607/005; US-5713937, 19980200, Nappholz et al., 607/030; US-5716384, 19980200, Snell, 607/030; US-5724985, 19980300, Snell et al., 128/697; US-5782890, 19980700, Wahlstrand et al., 607/032; US-5800465, 19980900, Thompson et al., 607/009; US-5833623, 19981100, Mann et al., 600/523; US-5836889, 19981100, Wyborny et al., 600/509; US-5891169, 19990400, Boheim et al., 607/004
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.